Pricing Log in Create free account

City Therapeutics, Inc (CTY) vs Inventiva S.A. Sponsored ADR (IVA)

City Therapeutics, Inc and Inventiva S.A. Sponsored ADR are both Biotechnology companies. City Therapeutics, Inc and Inventiva S.A. Sponsored ADR are of similar size ($882.9M and $867.9M).

Valuation

Metric CTY IVA Biotechnology median
P/E — n/m 10.60
P/S — 7.43 9.40
P/B — 2.13 2.13
Price to free cash flow — n/m 25.18
EV/EBITDA — n/m 0.66
EV/Sales — 1.54 9.02
Earnings yield — (94.51%) (32.88%)
Free cash flow yield — (94.32%) (23.13%)

Profitability

Metric CTY IVA Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin — 0.00% 0.00%
Net margin — (750.28%) 0.00%
Free cash flow margin — 0.00% 0.00%
Return on equity — 0.00% (51.96%)
Return on assets — 0.00% (46.06%)
Return on invested capital — 0.00% 0.00%

Growth

Metric CTY IVA Biotechnology median
Revenue growth (TTM) — 547.89% 6.76%
EPS growth (last fiscal year) — 35.44% 29.88%
Revenue growth, 5-year CAGR — 8.33% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CTY IVA Biotechnology median
Debt to equity — 1.13 0.00
Current ratio — 3.81 4.97
Net debt to EBITDA — 0.29 1.01

Dividend

Metric CTY IVA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CTY IVA Biotechnology median
Market cap 882.88m 867.93m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack